Biogen Inc. buy Needham & Company LLC
Start price
19.08.24
/
50%
€185.15
Target price
19.08.25
€258.12
Performance (%)
-5.97%
Price
30.09.24
€174.10
Summary
This prediction is currently active. With a performance of -5.97%, the BUY prediction by Needham___Company_LL is trending in the wrong direction. This prediction currently runs until 19.08.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -2.380% | -2.380% |
iShares Core DAX® | 3.523% | 2.930% |
iShares Nasdaq 100 | 1.026% | 2.688% |
iShares Nikkei 225® | -0.063% | -0.442% |
iShares S&P 500 | 0.557% | 1.759% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $285.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat